Accuray Europe and GE Capital Healthcare Equipment Finance have signed a collaboration agreement to develop sustainable financing options that will increase market access to the CyberKnife and TomoTherapy Systems.

These innovative solutions provide excellent treatment outcomes for a wide range of cancerous and non-cancerous tumors.

The new financing program will make it even easier for clinicians throughout Europe to offer their patients a non-invasive treatment option that delivers precise radiation therapy while maximizing patients’ quality of life during and after treatment.

"In today’s complex global healthcare environment, it’s important to keep the needs of physicians and their patients top-of-mind. The new financing program with GE Capital Healthcare Equipment Finance underscores our commitment to providing the cancer community with world-class options for accessing and treating cancer," said Lionel Hadjadjeba, senior vice president, worldwide commercial operations of Accuray.

The Accuray and GE Capital Healthcare Equipment Finance collaboration enables hospitals, clinics and medical practitioners to lease Accuray equipment and services through a turnkey offering that combines bunker construction, hardware, software, services and ongoing maintenance costs into one finance agreement.

The aim is to provide a flexible and sustainable funding solution for healthcare investments that make it possible for clinicians and patients to access Accuray’s precise, novel tumor treatments.

Multiple customers have already experienced how flexible and seamless financing radiotherapy systems throughout the entire procurement process can be. Accuray and GE Capital Healthcare Equipment Finance have most recently signed and closed two transactions in France with installations taking place over the early part of 2016. For example, Hospices Civils de Lyon (HCL), Lyon in France received financing for the acquisition of their TomoTherapy Systems through this collaboration.

"Our financing solutions aim at making life-saving technology more accessible to healthcare institutions, helping them provide superior clinical care and allowing them to focus their resources where it matters most to patients," added Christian Bernhard, General Manager, GE Capital Healthcare Equipment Finance in Europe.

About the CyberKnife and TomoTherapy Systems

The Accuray CyberKnife® M6 Series and TomoTherapy H Series treatment solutions cover the entire spectrum of radiation therapy needs.

The CyberKnife M6 Series enables precise, high-quality, dose distributions to be confidently delivered to the patient with extreme accuracy over a minimum number of treatments, reducing side effects and preserving patients’ quality of life. The CyberKnife System is the only robotic full-body radiosurgery system available today. The TomoTherapy H Series efficiently enables physicians to customize treatment plans for the entire range of radiation therapy patients and disease types.

Its innovative design enables treatment plans to be delivered with integrated, daily CT image guidance, enhancing accuracy and delivering highly precise, intensity-modulated radiation for optimal sparing of healthy tissue and critical structures.